- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有70家主力机构披露2025-06-30报告期持股数据，持仓量总计1.08亿股，占流通A股53.60%
- 波段诊断：
-
技术面诊股
诊断结果：6.4技术面打败了66%的股票
技术面评分前10的股票
近期的平均成本为25.80元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为25.80元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"25.80","date":1759138692,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，接近行业平均水平。
[{"date":"2025.09.30","stock":"1.02","trade":null,"ind":"0.52"},{"date":"2025.09.29","stock":"0.24","trade":null,"ind":"0.90"},{"date":"2025.09.26","stock":"0.08","trade":null,"ind":"-0.65"},{"date":"2025.09.25","stock":"0.04","trade":null,"ind":"-0.01"},{"date":"2025.09.24","stock":"1.03","trade":null,"ind":"0.83"},{"date":"2025.09.23","stock":"-1.75","trade":null,"ind":"-0.18"},{"date":"2025.09.22","stock":"-1.34","trade":null,"ind":"0.22"},{"date":"2025.09.19","stock":"-1.21","trade":null,"ind":"-0.30"},{"date":"2025.09.18","stock":"-2.19","trade":null,"ind":"-1.15"},{"date":"2025.09.17","stock":"-0.77","trade":null,"ind":"0.37"},{"date":"2025.09.16","stock":"0.07","trade":null,"ind":"0.04"},{"date":"2025.09.15","stock":"-1.31","trade":null,"ind":"-0.26"},{"date":"2025.09.12","stock":"0.44","trade":null,"ind":"-0.12"},{"date":"2025.09.11","stock":"0.51","trade":null,"ind":"1.65"},{"date":"2025.09.10","stock":"0.15","trade":null,"ind":"0.13"},{"date":"2025.09.09","stock":"-0.91","trade":null,"ind":"-0.51"},{"date":"2025.09.08","stock":"1.44","trade":null,"ind":"0.38"},{"date":"2025.09.05","stock":"1.81","trade":null,"ind":"1.24"},{"date":"2025.09.04","stock":"-0.26","trade":null,"ind":"-1.25"},{"date":"2025.09.03","stock":"-1.88","trade":null,"ind":"-1.16"},{"date":"2025.09.02","stock":"-1.56","trade":null,"ind":"-0.45"}]
东方生物,上证指数,医疗器械指数
压力支撑
该股压力位为25.61元，支撑位为25.14元。
[{"text":"\u538b\u529b\u4f4d","value":"25.61","date":1759161600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"25.14","date":1759161600,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.2资金面打败了45%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：10月02日 20:40
| 机构今日流向(万元) | 1023.20 | 机构5日流向(万元) | 1547.38 |
| 机构10日流向(万元) | -5844.05 | 机构20日流向(万元) | -11778.22 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少859.57万股，其中基金净减仓3家，主力净增仓6家，暂未发现中长期投资价值。
截止2025-06-30，共70家主力机构（一般法人4家，基金66家），持仓量总计10805.96万股，占流通A股53.60%
其中，基金持仓与2024-12-31相比：
增仓：9家 ，增持 72.56万股
减仓：12家 ，减持 76.64万股
新出现在主力名单中：40家 ，持有78.3万股
从主力名单中消失：34家 ，原持有888.63万股
其中，基金持仓与2024-12-31相比：
增仓：9家 ，增持 72.56万股
减仓：12家 ，减持 76.64万股
新出现在主力名单中：40家 ，持有78.3万股
从主力名单中消失：34家 ，原持有888.63万股
消息面诊股
诊断结果：5.5消息面打败了80%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 东方生物：9月29日获融资买入487.22万元
2025-09-30 - 东方生物：9月26日获融资买入340.17万元
2025-09-27 - 东方生物：9月25日获融资买入664.52万元
2025-09-26 - 东方生物：9月24日获融资买入259.48万元
2025-09-25 - 东方生物：多维布局构筑全球呼吸道检测版图，双线策略
2025-09-24 - 东方生物：9月23日获融资买入520.15万元
2025-09-24 - 东方生物：9月22日获融资买入286.55万元
2025-09-23 - 东方生物：控股子公司获两款注册证书 进一步完善国内
2025-09-22 - 东方生物子公司取得两款医疗器械产品注册证书
2025-09-22 - 东方生物：9月19日获融资买入809.65万元
2025-09-20
消息列表
| 一般消息 | 募资投向 | 2025-09-18 | |
| 一般消息 | 高管变动 | 取消监事会 | 2025-09-15 |
| 一般消息 | 高管变动 | 因个人工作原因 | 2025-09-10 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-29 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-08-29 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-29 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-30 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-04-30 |
| 重大利空 | 业绩预告 | 预计增亏 | 2025-01-17 |
| 一般消息 | 高管变动 | 因公司业务调整原因 | 2024-10-29 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了12%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2025.09.30","price":"0.52","value":null},{"date":"2025.09.29","price":"0.90","value":null},{"date":"2025.09.26","price":"-0.65","value":null},{"date":"2025.09.25","price":"-0.01","value":null},{"date":"2025.09.24","price":"0.83","value":null},{"date":"2025.09.23","price":"-0.18","value":null},{"date":"2025.09.22","price":"0.22","value":null},{"date":"2025.09.19","price":"-0.30","value":null},{"date":"2025.09.18","price":"-1.15","value":null},{"date":"2025.09.17","price":"0.37","value":null},{"date":"2025.09.16","price":"0.04","value":null},{"date":"2025.09.15","price":"-0.26","value":null},{"date":"2025.09.12","price":"-0.12","value":null},{"date":"2025.09.11","price":"1.65","value":null},{"date":"2025.09.10","price":"0.13","value":null},{"date":"2025.09.09","price":"-0.51","value":null},{"date":"2025.09.08","price":"0.38","value":null},{"date":"2025.09.05","price":"1.24","value":null},{"date":"2025.09.04","price":"-1.25","value":null},{"date":"2025.09.03","price":"-1.16","value":null},{"date":"2025.09.02","price":"-0.45","value":"-357279036.44"}]
上证指数,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 振德医疗 | 91.94% | 14.84% | 6.5分 |
| 2 | 奥精医疗 | 33.33% | 1.06% | 5.1分 |
| 3 | 浩欧博 | 26.36% | 9.62% | 4.9分 |
| 4 | 采纳股份 | 21.55% | 4.08% | 4.8分 |
| 5 | 华兰股份 | 19.17% | 4.73% | 5.9分 |
| 6 | 福瑞股份 | 18.11% | -5.87% | 4.8分 |
| 8 | 康为世纪 | 14.46% | 2.46% | 4.5分 |
| 10 | 南微医学 | 10.52% | 11.75% | 6.9分 |
| 12 | 新产业 | 9.67% | 2.91% | 5.5分 |
| 14 | 麦克奥迪 | 7.91% | 3.63% | 5.5分 |
| 16 | 澳华内镜 | 5.46% | 11.35% | 5.7分 |
| 18 | 天臣医疗 | 4.97% | 0.62% | 5.3分 |
| 20 | 硕世生物 | 4.55% | -1.53% | 4.9分 |
| 22 | 楚天科技 | 4.14% | -0.34% | 4.8分 |
| 24 | 威高骨科 | 3.46% | 0.77% | 5.6分 |
| 26 | 圣湘生物 | 2.87% | 7.85% | 6.2分 |
| 28 | 爱威科技 | 2.53% | 3.85% | 5.9分 |
| 30 | 奕瑞科技 | 2.19% | 3.63% | 6.3分 |
| 32 | 安杰思 | 1.26% | 1.58% | 6.1分 |
| 34 | 五洲医疗 | 0.93% | 0.35% | 4.5分 |
| 36 | 黄山胶囊 | 0.80% | 3.55% | 5.7分 |
| 38 | 联影医疗 | 0.76% | 5.43% | 5.8分 |
| 40 | 赛科希德 | 0.53% | 2.35% | 4.8分 |
| 42 | 济民健康 | -0.18% | -3.48% | 4.2分 |
| 44 | 迪瑞医疗 | -0.36% | 1.97% | 4.7分 |
| 46 | 天益医疗 | -0.43% | 0.32% | 5.3分 |
| 48 | 可孚医疗 | -0.68% | 2.31% | 5.7分 |
| 50 | 睿昂基因 | -0.83% | 5.58% | 5.3分 |
| 52 | 英诺特 | -0.97% | -0.45% | 4.3分 |
| 54 | 普门科技 | -1.57% | -0.14% | 5.5分 |
| 56 | 明德生物 | -1.86% | 2.04% | 4.9分 |
| 58 | 山东药玻 | -1.92% | 1.32% | 5.5分 |
| 60 | 新华医疗 | -2.32% | -0.25% | 5.2分 |
| 62 | 万泰生物 | -2.84% | 0.66% | 4.7分 |
| 64 | 拱东医疗 | -3.11% | -0.05% | 5.0分 |
| 66 | 宝莱特 | -3.15% | 2.75% | 4.9分 |
| 68 | 亚辉龙 | -3.26% | 2.03% | 5.2分 |
| 70 | 康泰医学 | -3.42% | 0.06% | 4.6分 |
| 72 | 万孚生物 | -3.49% | 0.90% | 4.8分 |
| 74 | 超研股份 | -3.53% | 0.86% | 4.6分 |
| 76 | 正川股份 | -3.77% | 2.21% | 4.2分 |
| 78 | 三鑫医疗 | -3.89% | -1.08% | 5.3分 |
| 80 | 正海生物 | -4.28% | 1.12% | 4.7分 |
| 82 | 爱迪特 | -4.49% | 0.48% | 5.1分 |
| 84 | 基蛋生物 | -4.55% | -0.87% | 5.1分 |
| 86 | 迈克生物 | -4.59% | -0.09% | 5.0分 |
| 88 | 东方生物 | -4.82% | 2.42% | 4.8分 |
| 90 | 昊海生科 | -4.89% | 1.09% | 5.5分 |
| 92 | 欧普康视 | -4.99% | 2.27% | 5.4分 |
| 94 | 迈普医学 | -5.12% | -0.58% | 5.0分 |
| 96 | 安必平 | -5.72% | 1.91% | 4.7分 |
| 98 | 科华生物 | -5.74% | 0.79% | 4.7分 |
| 100 | 理邦仪器 | -5.93% | 0.93% | 5.5分 |
| 102 | 瑞迈特 | -6.69% | -0.12% | 5.6分 |
| 104 | 翔宇医疗 | -6.87% | 1.03% | 5.4分 |
| 106 | 健尔康 | -7.06% | 0.28% | 4.7分 |
| 108 | 佰仁医疗 | -7.09% | 0.64% | 5.4分 |
| 110 | 微电生理 | -7.33% | 0.50% | 5.4分 |
| 112 | 利德曼 | -7.81% | 0.13% | 4.5分 |
| 114 | 热景生物 | -9.03% | -5.25% | 4.8分 |
| 116 | 威高血净 | -9.70% | 1.24% | 5.5分 |
| 118 | 仁度生物 | -10.23% | 1.61% | 4.5分 |
| 120 | - | -10.78% | 12.61% | 分 |
| 122 | 赛诺医疗 | -12.08% | 3.02% | 5.2分 |
| 124 | 爱朋医疗 | -12.25% | 3.41% | 4.3分 |
| 126 | 三友医疗 | -17.48% | 0.82% | 5.2分 |
| 128 | - | -57.89% | -14.16% | 分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 117/251 ， 94/251。
[{"date":"2025-06-30","value":"-2.49","vol":"2.27"},{"date":"2025-03-31","value":"-1.75","vol":"1.15"},{"date":"2024-12-31","value":"-7.51","vol":"0.53"},{"date":"2024-09-30","value":"-3.66","vol":"4.75"},{"date":"2024-06-30","value":"-2.10","vol":"3.53"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-2.49 | -1.75 | -7.51 | -3.66 | -2.10 |
| 行业(%) | 2.27 | 1.15 | 0.53 | 4.75 | 3.53 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"37.62","vol":"52.10"},{"date":"2025-03-31","value":"27.36","vol":"51.81"},{"date":"2024-12-31","value":"31.74","vol":"52.63"},{"date":"2024-09-30","value":"34.69","vol":"53.58"},{"date":"2024-06-30","value":"35.61","vol":"53.70"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
37.62 | 27.36 | 31.74 | 34.69 | 35.61 |
| 行业(%) | 52.10 | 51.81 | 52.63 | 53.58 | 53.70 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 70/251 ， 55/251。
[{"date":"2025-06-30","value":"-3.62","vol":"-1.71"},{"date":"2025-03-31","value":"4.94","vol":"-0.92"},{"date":"2024-12-31","value":"0.95","vol":"0.64"},{"date":"2024-09-30","value":"0.83","vol":"0.79"},{"date":"2024-06-30","value":"-16.61","vol":"0.16"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-3.62 | 4.94 | 0.95 | 0.83 | -16.61 |
| 行业(%) | -1.71 | -0.92 | 0.64 | 0.79 | 0.16 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"-7.58","vol":"-20.27"},{"date":"2025-03-31","value":"-71.41","vol":"-4.25"},{"date":"2024-12-31","value":"-33.06","vol":"-24.11"},{"date":"2024-09-30","value":"-262.17","vol":"-20.40"},{"date":"2024-06-30","value":"-535.56","vol":"8.56"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-7.58 | -71.41 | -33.06 | -262.17 | -535.56 |
| 行业(%) | -20.27 | -4.25 | -24.11 | -20.40 | 8.56 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 121/251 ， 79/251。
[{"date":"2025-06-30","value":"0.05","vol":"0.17"},{"date":"2025-03-31","value":"0.02","vol":"0.08"},{"date":"2024-12-31","value":"0.10","vol":"0.35"},{"date":"2024-09-30","value":"0.08","vol":"0.26"},{"date":"2024-06-30","value":"0.05","vol":"0.18"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.05 | 0.02 | 0.10 | 0.08 | 0.05 |
| 行业(次) | 0.17 | 0.08 | 0.35 | 0.26 | 0.18 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.81","vol":"1.13"},{"date":"2025-03-31","value":"0.46","vol":"0.55"},{"date":"2024-12-31","value":"1.72","vol":"2.33"},{"date":"2024-09-30","value":"1.11","vol":"1.67"},{"date":"2024-06-30","value":"0.70","vol":"1.13"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.81 | 0.46 | 1.72 | 1.11 | 0.70 |
| 行业(次) | 1.13 | 0.55 | 2.33 | 1.67 | 1.13 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 119/251 ， 95/251。
[{"date":"2025-06-30","value":"-32.67","vol":"15.06"},{"date":"2025-03-31","value":"-28.28","vol":"4.01"},{"date":"2024-12-31","value":"11.05","vol":"29.58"},{"date":"2024-09-30","value":"-14.53","vol":"15.37"},{"date":"2024-06-30","value":"-51.21","vol":"13.04"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -32.67 | -28.28 | 11.05 | -14.53 | -51.21 |
| 行业 | 15.06 | 4.01 | 29.58 | 15.37 | 13.04 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.94","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"4.05","vol":"2.19"},{"date":"2024-09-30","value":"","vol":"0.01"},{"date":"2024-06-30","value":"3.49","vol":"2.31"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 1.94 | - | 4.05 | - | 3.49 |
| 行业 | 1.57 | 0.00 | 2.19 | 0.01 | 2.31 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 65/251 ， 75/251。
[{"date":"2025-06-30","value":"4.21","vol":"5.50"},{"date":"2025-03-31","value":"4.04","vol":"5.89"},{"date":"2024-12-31","value":"3.31","vol":"5.34"},{"date":"2024-09-30","value":"4.09","vol":"5.97"},{"date":"2024-06-30","value":"4.05","vol":"5.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
4.21 | 4.04 | 3.31 | 4.09 | 4.05 |
| 行业 | 5.50 | 5.89 | 5.34 | 5.97 | 5.95 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"3.65","vol":"4.40"},{"date":"2025-03-31","value":"3.54","vol":"4.77"},{"date":"2024-12-31","value":"2.94","vol":"4.32"},{"date":"2024-09-30","value":"3.59","vol":"4.82"},{"date":"2024-06-30","value":"3.58","vol":"4.90"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.65 | 3.54 | 2.94 | 3.59 | 3.58 |
| 行业 | 4.40 | 4.77 | 4.32 | 4.82 | 4.90 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 85/251 ， 84/251。
[{"date":"2025-06-30","value":"13.31","vol":"22.01"},{"date":"2025-03-31","value":"14.11","vol":"21.24"},{"date":"2024-12-31","value":"16.10","vol":"21.92"},{"date":"2024-09-30","value":"14.37","vol":"21.09"},{"date":"2024-06-30","value":"14.88","vol":"21.07"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
13.31 | 14.11 | 16.10 | 14.37 | 14.88 |
| 行业(%) | 22.01 | 21.24 | 21.92 | 21.09 | 21.07 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.16","vol":"0.58"},{"date":"2025-03-31","value":"0.17","vol":"0.57"},{"date":"2024-12-31","value":"0.20","vol":"0.55"},{"date":"2024-09-30","value":"0.17","vol":"0.38"},{"date":"2024-06-30","value":"0.18","vol":"0.37"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.16 | 0.17 | 0.20 | 0.17 | 0.18 |
| 行业(%) | 0.58 | 0.57 | 0.55 | 0.38 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"49.20","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"20.68","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-3.98","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-5.29","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]